XML 33 R52.htm IDEA: XBRL DOCUMENT v3.3.0.814
Business Combinations (Pro Forma Information) (Details) - NPS Pharma - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Pro Forma Information    
Revenues $ 4,730.9 $ 4,603.4
Net income from continuing operations $ 1,005.6 $ 1,028.8
Net income from continuing operations per share - basic $ 1.704 $ 1.755
Net income from continuing operations per share - diluted $ 1.695 $ 1.738
Pro Forma Data Adjustments    
An adjustment to increase amortization of intangible assets $ (21.2) $ (126.5)
Increase/(decrease) to net income to reflect acquisition related costs 105.2 (105.2)
Decrease to net income to reflect the additional interest expense   (16.7)
Increase/(decrease) to net income to reflect the fair value adjustment to acquisition date inventory. $ 13.4 $ (13.4)